<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02152176</url>
  </required_header>
  <id_info>
    <org_study_id>AOI 2013-08</org_study_id>
    <nct_id>NCT02152176</nct_id>
  </id_info>
  <brief_title>Morphine Titration by Patient Self-controlled by a Mechanical Device Versus Administration by the Nurse for Patients With Severe Acute Pain in the Emergency Department</brief_title>
  <acronym>TACIDOU</acronym>
  <official_title>Titration Morphinique autocontrôlée Par le Patient Par un Dispositif mécanique à Usage Unique Versus Administration Par l'infirmière Chez Les Patients Ayant Une Douleur aiguë sévère Aux Urgences.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intense acute pain is a common reason for Emergency admittance and its management is one of
      the major public health goals.

      In the recommendations formalized experts, it is recommended to use a protocol titration with
      morphine bolus of 2 mg (for patients less than 60 kg) or 3 mg (for patients over 60 kg)
      repeated every 5 minutes with a target of the Visual Analog Scale less than or equal to 30.

      Despite these specific recommendations and a broad awareness of the teams, management of pain
      remains to be improved, the major difficulty of morphine titration at the emergency
      department being the availability of paramedical personnel to perform revaluations and
      reinjection. Thus, effective analgesia would be obtained in 50% of cases to 30 minutes.

      The investigators want to study the self-controlled morphine titration by the patient by a
      mechanical device for single use (efficacy/safety).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale &lt;30</measure>
    <time_frame>30min</time_frame>
    <description>Evaluate the effectiveness of the analgesia of morphine titration self-controlled by the patient using a PCA device for single use (&quot;PCA&quot; group) opposing to an opioid titration carried out by the nurse (group 'Control')</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the effectiveness in the group Patient Controlled Analgesy</measure>
    <time_frame>4h</time_frame>
    <description>time to obtain effective analgesia from prescirption
consumption of morphine
Visual Analog Scale evolution
percentage of patients relieved defined by VAS &lt;40, 1 hour after the prescription of opioid titration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>4h</time_frame>
    <description>patient satisfaction
nurse satisfaction
time to prepare morphine titration</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Assess the safety in the group Patient Controlled Analgesy</measure>
    <time_frame>4h</time_frame>
    <description>adverse events du to morphine
adverse events du to medical/nursing support</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Acute Pain</condition>
  <arm_group>
    <arm_group_label>Patient Controlled Analgesy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Titration of morphine by Patient Controlled Analgesy. The opioid titration will be performed by the patient using PCA (Vygon Freedom 5) according to the principle of self with a refractory period of 5 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>titration will be perform in the usual manner in accordance with the recommendations : a nurse will assess pain using a visual analog scale in the control group to assess the need for a new bolus of morphine</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Titration of morphine by Patient Controlled Analgesy</intervention_name>
    <description>PCA is never used for titration but only for relay of titration. Self-controlled analgesia by PCA is our intervention.</description>
    <arm_group_label>Patient Controlled Analgesy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission to an emergency department

          -  Acute pain (Visual Analog Scale &gt; 60)

          -  Able to assess pain using the numerical scale

          -  Prescription of morphine titration

        Exclusion Criteria:

          -  Physical or mental disorders limiting the understanding and / or use of a PCA

          -  History of allergy to morphine / hypersensitivity to any component

          -  Long-term treatment morphine

          -  Opioid therapy administered prior to inclusion

          -  Analgesic treatment level 2 (codeine, tramadol, nefopam ...) administered prior to
             inclusion or planned

          -  History of Substance Abuse

          -  Severe respiratory insufficiency

          -  Severe hepatic impairment

          -  Head trauma

          -  Intracranial hypertension

          -  Uncontrolled epilepsy

          -  Pregnant or lactating

          -  Patient jailed

          -  Incapacitated adult under guardianship

          -  Incapable of giving informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ROY Pierre-Marie, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>UH Angers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>SCHOTTE Thibault, Physician</last_name>
    <role>Principal Investigator</role>
    <affiliation>UH Angers</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SCHOTTE Thibault</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHOUKROUN Jacques</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2014</study_first_submitted>
  <study_first_submitted_qc>May 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2014</study_first_posted>
  <last_update_submitted>June 29, 2016</last_update_submitted>
  <last_update_submitted_qc>June 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>analgesia</keyword>
  <keyword>morphine</keyword>
  <keyword>PCA</keyword>
  <keyword>Nurse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

